Gilead Sciences Inc. CEO Daniel O'Day's compensation rose 4.8% last year to $23.7 million — roughly $97 for every buck made ...

Here is an overview of the Marion area's boys track season before it starts this weekend. See who looks strong for 2025.

Gilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over ...

With the FDA appearing to be undergoing major disruption under new leadership, BofA analyst Tim Anderson says one way to assess the risk from ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The Investment Committee give you their top stocks to watch for the second half. House cancels rest of votes for week after GOP floor rebellion Eddie Murphy says Sidney Poitier urged him not to star ...

Protagonist (Nasdaq: PTGX) is one of a handful of Bay Area drug developers ready to ask the Food and Drug Administration to ...

PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV ...

As the sixth and final season of The Handmaid’s Tale is nearing its premiere next week, production on its sequel series The ...

Hulu announced that it is developing a series based on Margaret Atwood's 2019 novel "The Testaments," which is a follow-up to ...

Tomas Cihlar knew all too well that despite initial successes with combination treatment, HIV was firmly holding ground ...

Bruce Miller knew for a long time how he wanted to bring the story to a conclusion,' says EP Eric Tuchman. 'It's about June's ...